🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

US Stocks Fall; Pfizer Swings To Q3 Loss

Published 31/10/2023, 13:52
© Reuters US Stocks Fall; Pfizer Swings To Q3 Loss
PFE
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stocks traded lower this morning, following the release of economic reports.

Following the market opening Tuesday, the Dow traded down 0.25% to 32,845.12 while the NASDAQ fell 0.50% to 12,726.17. The S&P 500 also fell, dropping, 0.14% to 4,161.09.

Check This Out: $2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

Leading and Lagging Sectors

Communication services shares jumped by 2.1% on Tuesday.

In trading on Tuesday, energy shares rose by just 0.3%.

Top Headline

Pfizer Inc (NYSE: PFE) reported a loss for the third quarter.

Pfizer reported quarterly adjusted EPS loss of $(0.17) versus a consensus loss of $(0.32), down from EPS income of $0.67 in Q2 and $1.78 a year ago. The company reported a 42% slump in Q3 sales to $13.23 billion, down from $22.64 billion a year ago, beating the consensus of $12.72 billion.

Equities Trading UP

SciSparc Ltd. (NASDAQ: SPRC) shares shot up 77% to $6.03 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment.

Shares of Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) got a boost, shooting 48% to $0.3165 after the company received an Innovation Technology contract from Vizient for its novel AI-driven precision heart disease tests.

Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares were also up, gaining 23% to $0.1144 after the company announced it has completed the divestiture of AVTX-800 Series.

Equities Trading DOWN

Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares dropped 77% to $0.8671. The company announced that its drug VAL-083 did not outperform existing treatments for glioblastoma, a severe brain cancer.

Shares of Galera Therapeutics, Inc. (NASDAQ: GRTX) were down 52% to $0.1005 after the company said GRECO-2 trial did not pass futility analysis.

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) was down, falling 46% to $58.26 after the company said EMBARK did not meet the primary endpoint.

Also Check This Out: Top 3 Consumer Stocks That Could Sink Your Portfolio In Q4

Commodities

In commodity news, oil traded up 0.1% to $82.40 while gold traded up 0.1% at $2,006.10.

Silver traded down 0.9% to $23.175 on Tuesday while copper fell 0.7% to $3.6335.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 gained 0.7%, London’s FTSE 100 rose 0.5% while Spain’s IBEX 35 Index climbed 0.6% The German DAX gained 0.6% French CAC 40 climbed 1.1%, while Italy’s FTSE MIB Index jumped 1.6%.

The inflation rate in the Eurozone eased to 2.9% year-over-year in October, falling to its lowest level since July 2021. The Eurozone economy contracted 0.1% on quarter during the three months to Sept. 2023, compared to revised 0.2% increase in the prior quarter.

The French economy expanded by 0.1% in the third quarter, slowing from a revised 0.6% increase in the prior quarter. France's consumer price inflation eased to 4% year-over-year in October from 4.9% in the prior month, while producer prices increased 0.7% month-over-month for September. German import prices declined 14.3% year-over-year in September, while retail sales in Germany fell 0.8% month-over-month for September.

Asia Pacific Markets

Asian markets closed mostly lower on Tuesday, with Japan’s Nikkei 225 rising 0.53%, Hong Kong’s Hang Seng Index falling 1.69% and China’s Shanghai Composite Index falling 0.09%. India’s S&P BSE Sensex, meanwhile, slipped around 0.1%.

The Bank of Japan maintained its key short-term interest rate at -0.1%. Japanese housing starts fell by 6.8% year-over-year in September, while retail sales in Japan increased 5.8% year-over-year in September. Industrial production climbed by 0.2% month-over-month, while unemployment rate declined to 2.6% in September from 2.7% in the previous month.

The official NBS manufacturing PMI in China declined to 49.5 in October from 50.2 a month ago, while official NBS non-manufacturing PMI fell to 50.6 from 51.7. Hong Kong’s economy grew by 4.1% year-over-year in the third quarter compared to a 1.5% increase in the prior period.

Economics

The S&P CoreLogic Case-Shiller 20-city home price index climbed 2.2% year-over-year in August versus a 0.2% increase in July.

The FHFA house price index increased by 0.6% from the prior month in August versus a 0.8% rise in July.

Compensation costs for civilian workers rose by 1.1% in the third quarter.

Now Read This: These 3 Real Estate Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.